The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 24, Pages 6209
Publisher
MDPI AG
Online
2021-12-10
DOI
10.3390/cancers13246209
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer
- (2021) Sima Singh et al. DRUG DISCOVERY TODAY
- Emerging drugs for the treatment of triple-negative breast cancer: a focus on phase II immunotherapy trials
- (2021) Peter E. Hall et al. EXPERT OPINION ON EMERGING DRUGS
- RNA-Based CTC Analysis Provides Prognostic Information in Metastatic Breast Cancer
- (2021) Areti Strati et al. Diagnostics
- Tumor-associated macrophages-mediated CXCL8 infiltration enhances breast cancer metastasis: Suppression by Danirixin
- (2021) Gang Nie et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Knockdown of ALDH1A3 reduces breast cancer stem cell marker CD44 via the miR‑7‑TGFBR2‑Smad3‑CD44 regulatory axis
- (2021) Meng Pan et al. Experimental and Therapeutic Medicine
- Molecular Mechanisms Associated with Brain Metastases in HER2-Positive and Triple Negative Breast Cancers
- (2021) Sarah Bryan et al. Cancers
- Immunotherapy Treatment for Triple Negative Breast Cancer
- (2021) Elizabeth R. Berger et al. Pharmaceuticals
- The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition
- (2021) S. Loi et al. ANNALS OF ONCOLOGY
- Treatment landscape of triple-negative breast cancer — expanded options, evolving needs
- (2021) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer
- (2020) K.G.K. Deepak et al. PHARMACOLOGICAL RESEARCH
- The prognostic significance of ALDH1A1 expression in early invasive breast cancer
- (2020) Maryam Althobiti et al. HISTOPATHOLOGY
- Heterogeneity of Stemlike Circulating Tumor Cells in Invasive Breast Cancer
- (2020) Olga E. Savelieva et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumorigenic and Metastatic Role of CD44−/low/CD24−/low Cells in Luminal Breast Cancer
- (2020) Rajeev Vikram et al. Cancers
- Editorial: The Role of Breast Cancer Stem Cells in Clinical Outcomes
- (2020) Dayanidhi Raman et al. Frontiers in Oncology
- Pyrvinium pamoate induces death of triple-negative breast cancer stem-like cells and reduces metastases through effects on lipid anabolism
- (2020) Rosanna Dattilo et al. CANCER RESEARCH
- Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer – A comprehensive review from chemotherapy to immunotherapy
- (2020) Parham Jabbarzadeh Kaboli et al. PHARMACOLOGICAL RESEARCH
- The Changing Paradigm for the Treatment of HER2-Positive Breast Cancer
- (2020) Aena Patel et al. Cancers
- Effects of Cancer Stem Cells in Triple-Negative Breast Cancer and Brain Metastasis: Challenges and Solutions
- (2020) Kha-Liang Lee et al. Cancers
- Class I histone deacetylase inhibitor suppresses vasculogenic mimicry by enhancing the expression of tumor suppressor and anti-angiogenesis genes in aggressive human TNBC cells
- (2019) Aparna Maiti et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy
- (2019) Rama Soundararajan et al. Cancers
- Immunogenicity of Tumor Initiating Stem Cells: Potential Applications in Novel Anticancer Therapy
- (2019) Durga Khandekar et al. Frontiers in Oncology
- Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
- (2019) Park et al. Cancers
- The Hedgehog Signaling Pathway: A Viable Target in Breast Cancer?
- (2019) Priyanka Bhateja et al. Cancers
- Notch signaling in breast cancer: From pathway analysis to therapy
- (2019) B. Madhu Krishna et al. CANCER LETTERS
- The great escape: tumour cell plasticity in resistance to targeted therapy
- (2019) Soufiane Boumahdi et al. NATURE REVIEWS DRUG DISCOVERY
- Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance
- (2019) Sangita Sridharan et al. Frontiers in Oncology
- Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness
- (2019) Sangita Sridharan et al. Frontiers in Oncology
- Cancer stem cells in triple-negative breast cancer: a potential target and prognostic marker
- (2018) Christopher J O'Conor et al. Biomarkers in Medicine
- Targeting Brain-Adaptive Cancer Stem Cells Prohibits Brain Metastatic Colonization of Triple-Negative Breast Cancer
- (2018) Ding Ren et al. CANCER RESEARCH
- Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
- (2018) Nithya Krishnamurthy et al. CANCER TREATMENT REVIEWS
- STAT3 as a promising chemoresistance biomarker associated with the CD44 +/high /CD24 -/low /ALDH + BCSCs-like subset of the triple-negative breast cancer (TNBC) cell line
- (2018) Milene Pereira Moreira et al. EXPERIMENTAL CELL RESEARCH
- Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition
- (2018) Eunhye Oh et al. INTERNATIONAL JOURNAL OF CANCER
- Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066
- (2018) Cong-Cong Cheng et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer
- (2018) Mingshan Liu et al. Molecular Cancer
- Taming the Notch Transcriptional Regulator for Cancer Therapy
- (2018) Luca Tamagnone et al. MOLECULES
- eIF4A alleviates the translational repression mediated by classical secondary structures more than by G-quadruplexes
- (2018) Joseph A Waldron et al. NUCLEIC ACIDS RESEARCH
- Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer
- (2018) Yinnan Chen et al. Advanced Science
- Cancer stem cell markers ALDH1 and CD44+/CD24- phenotype and their prognosis impact in invasive ductal carcinoma
- (2018) Iris Rabinovich et al. EUROPEAN JOURNAL OF HISTOCHEMISTRY
- Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance
- (2018) Sònia Palomeras et al. MOLECULES
- Breast cancer stem cells: Features, key drivers and treatment options
- (2018) Jürgen Dittmer SEMINARS IN CANCER BIOLOGY
- Resistance of primary breast cancer cells with enhanced pluripotency and stem cell activity to sex hormonal stimulation and suppression
- (2018) Mostafa Nasr et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models
- (2018) Xia Liu et al. Cancer Discovery
- The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
- (2018) Massimo Cristofanilli et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC)
- (2017) Fei Ma et al. MEDICINE
- Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma
- (2017) A Po et al. ONCOGENE
- Interferon-beta represses cancer stem cell properties in triple-negative breast cancer
- (2017) Mary R. Doherty et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer cell dormancy: mechanisms and implications of cancer recurrence and metastasis
- (2017) Xiaolei Gao et al. OncoTargets and Therapy
- CD44+/CD24‑ phenotype predicts a poor prognosis in triple‑negative breast cancer
- (2017) Hui Wang et al. Oncology Letters
- Wnt signaling in triple-negative breast cancer
- (2017) SÖ-G Pohl et al. Oncogenesis
- Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer
- (2016) Maria Cristina Rangel et al. BREAST CANCER RESEARCH AND TREATMENT
- Both bulk and cancer stem cell subpopulations in triple-negative breast cancer are susceptible to Wnt, HDAC, and ERα coinhibition
- (2016) Andrew Sulaiman et al. FEBS LETTERS
- Cancer stem cells and chemoresistance: The smartest survives the raid
- (2016) Jihe Zhao PHARMACOLOGY & THERAPEUTICS
- The hedgehog pathway in triple-negative breast cancer
- (2016) Joyce G. Habib et al. Cancer Medicine
- Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials
- (2015) M. V. Dieci et al. ANNALS OF ONCOLOGY
- Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer
- (2015) M Zuo et al. BRITISH JOURNAL OF CANCER
- Wnt/ -Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells
- (2015) G.-B. Jang et al. CANCER RESEARCH
- SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer
- (2015) C. M. Della Corte et al. CLINICAL CANCER RESEARCH
- New Findings on Breast Cancer Stem Cells: A Review
- (2015) Azam Bozorgi et al. Journal of Breast Cancer
- Targeting GLI factors to inhibit the Hedgehog pathway
- (2015) Paola Infante et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cripto-1 as a novel therapeutic target for triple negative breast cancer
- (2015) Nadia P. Castro et al. Oncotarget
- Selective killing of breast cancer cells expressing activated CD44 using CD44 ligand-coated nanoparticles in vitro and in vivo
- (2015) Cuixia Yang et al. Oncotarget
- Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer
- (2015) Francesca Collina et al. Biomed Research International
- Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts
- (2015) Sílvia Cufí et al. Oncotarget
- Breast cancer stem cells: Multiple capacities in tumor metastasis
- (2014) Shao-Qing Geng et al. CANCER LETTERS
- Efficacy of biological agents in metastatic triple-negative breast cancer
- (2014) Annalisa Bramati et al. CANCER TREATMENT REVIEWS
- Metastatic Stem Cells: Sources, Niches, and Vital Pathways
- (2014) Thordur Oskarsson et al. Cell Stem Cell
- Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells
- (2014) A. Janzer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
- (2014) Suling Liu et al. Stem Cell Reports
- Oncogenic somatic events in tissue-specific stem cells: A role in cancer recurrence?
- (2013) F.P. Hartwig et al. AGEING RESEARCH REVIEWS
- Wnt signaling in triple negative breast cancer is associated with metastasis
- (2013) Nandini Dey et al. BMC CANCER
- WNT10B/β-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer
- (2013) Peter Wend et al. EMBO Molecular Medicine
- CD133 expression in circulating tumor cells from breast cancer patients: Potential role in resistance to chemotherapy
- (2013) Rosa Nadal et al. INTERNATIONAL JOURNAL OF CANCER
- Invasive cancers are not necessarily from preformedin situtumours - an alternative way of carcinogenesis from misplaced stem cells
- (2013) Rui-An Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
- (2013) Sherene Loi et al. JOURNAL OF CLINICAL ONCOLOGY
- CD44/CD24 as potential prognostic markers in node-positive invasive ductal breast cancer patients treated with adjuvant chemotherapy
- (2013) Agnieszka Adamczyk et al. JOURNAL OF MOLECULAR HISTOLOGY
- Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells
- (2013) Birdal Bilir et al. Journal of Translational Medicine
- Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
- (2013) Irène Baccelli et al. NATURE BIOTECHNOLOGY
- Differential Activation of Wnt-β-Catenin Pathway in Triple Negative Breast Cancer Increases MMP7 in a PTEN Dependent Manner
- (2013) Nandini Dey et al. PLoS One
- Breast cancer, side population cells and ABCG2 expression
- (2012) K.M. Britton et al. CANCER LETTERS
- Genomic Profiling of Isolated Circulating Tumor Cells from Metastatic Breast Cancer Patients
- (2012) M. J. M. Magbanua et al. CANCER RESEARCH
- Cancer stem cells
- (2012) Zuoren Yu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer
- (2012) Lisa A. Carey et al. JOURNAL OF CLINICAL ONCOLOGY
- CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma
- (2012) Yan Lin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Generation of anti-Notch antibodies and their application in blocking Notch signalling in neural stem cells
- (2012) Ronny Falk et al. METHODS
- Metformin: An Emerging New Therapeutic Option for Targeting Cancer Stem Cells and Metastasis
- (2012) Ramandeep Rattan et al. Journal of Oncology
- The Role of Breast Cancer Stem Cells in Metastasis and Therapeutic Implications
- (2011) Marco A. Velasco-Velázquez et al. AMERICAN JOURNAL OF PATHOLOGY
- Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma
- (2011) Po Zhao et al. CANCER SCIENCE
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Metformin Represses Self-Renewal of the Human Breast Carcinoma Stem Cells via Inhibition of Estrogen Receptor-Mediated OCT4 Expression
- (2011) Ji-Won Jung et al. PLoS One
- Wnt Proteins Are Self-Renewal Factors for Mammary Stem Cells and Promote Their Long-Term Expansion in Culture
- (2010) Yi Arial Zeng et al. Cell Stem Cell
- Targeting Hedgehog -- a Cancer Stem Cell Pathway
- (2010) A. A. Merchant et al. CLINICAL CANCER RESEARCH
- Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growth
- (2010) Dalit Barkan et al. EUROPEAN JOURNAL OF CANCER
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer
- (2009) Panayiotis A. Theodoropoulos et al. CANCER LETTERS
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Cancer stem cells: mirage or reality?
- (2009) Piyush B Gupta et al. NATURE MEDICINE
- A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells
- (2008) Ling-Yuan Kong et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More